Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists. I. Production, Isolation, Characterization and Biological Activities.

The Journal of Antibiotics
1995.0

Abstract

Sulfobacins A and B, novel von Willebrand factor (vWF) receptor antagonists, have been isolated from the culture broth of Chryseobacterium sp. (Flavobacterium sp.) NR 2993 by ethyl acetate extraction, and by Sephadex LH-20 and silica gel column chromatographies. The physico-chemical properties of the sulfobacins indicate that their structures are completely different from that of aurintricarboxylic acid, the one known vWF receptor antagonist. Sulfobacins A and B inhibit the binding of vWF to its receptor with IC50S of 0.47 and 2.2 microM, respectively. Sulfobacin A also inhibits ristocetin-induced agglutination in human platelets fixed with paraformaldehyde with an IC50 of 0.58 microM.

Knowledge Graph

Similar Paper

Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists. I. Production, Isolation, Characterization and Biological Activities.
The Journal of Antibiotics 1995.0
Tetrafibricin, a novel fibrinogen receptor antagonist. I. Taxonomy, fermentation, isolation, characterization and biological activities.
The Journal of Antibiotics 1993.0
Studies on WF-5239, a new potent platelet aggregation inhibitor.
The Journal of Antibiotics 1984.0
Bacithrocins A, B and C, novel thrombin inhibitors.
The Journal of Antibiotics 1994.0
Purification and Characterization of Bitiscetin, a Novel von Willebrand Factor Modulator Protein fromBitis arietansSnake Venom
Biochemical and Biophysical Research Communications 1996.0
WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. No. 89009. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
The Journal of Antibiotics 1992.0
Tetrafibricin: A nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I) its GPIIB/IIIA blockage on solid phase binding assay
Thrombosis Research 1993.0
Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (.+-.)-(5Z)-7-[3-endo[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-exo-yl]heptenoic acid
Journal of Medicinal Chemistry 1988.0
WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. No. 89009. II. Biological characterization and pharmacological characterization of WS009 A and B.
The Journal of Antibiotics 1992.0
Studies on WB-3559 A,B,C and D, new potent fibrinolytic agents. I. Discovery, identification, isolation and characterization.
The Journal of Antibiotics 1985.0